Liothyronine – RMOC guidance

The four NHS England Regional Medicines Optimisation Committees (RMOCs) function as a single national system, with one committee meeting every month to produce once-for-England recommendations and resources.

Newly published RMOC Guidance on Prescribing of Liothyronine supplements and expands on NHS England / NHS Clinical Commissioners Guidance on Items which should not routinely be
prescribed in primary care – and includes a draft shared care guideline to be used when consultant endocrinologists advise a trial combination of levothyroxine with liothyronine for patients with persistent symptoms of hypothyroidism despite optimised levothyroxine therapy and full exploration of alternative causes.

During the 12 months to 30th June 2018, the 16 CCGs linked with NECS MO spend almost £1.3 million on liothyronine prescriptions for approximately 330 patients (almost £3.9K per patient per year).